GAUDIUMIVF — Gaudium IVF and Women Health Balance Sheet
0.000.00%
- IN₹7.39bn
- IN₹7.50bn
- IN₹1.04bn
Annual balance sheet for Gaudium IVF and Women Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 15.8 | 151 | 119 | 72.1 | 140 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 115 | 10.1 | 200 | 331 | 534 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 136 | 184 | 383 | 538 | 733 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 38.9 | 55.5 | 73.5 | 78.7 | 86.8 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 178 | 366 | 573 | 885 | 1,931 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 59.3 | 96 | 197 | 380 | 385 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 84.8 | 139 | 240 | 422 | 408 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 92.9 | 227 | 333 | 463 | 1,523 |
| Total Liabilities & Shareholders' Equity | 178 | 366 | 573 | 885 | 1,931 |
| Total Common Shares Outstanding |